Glycerin

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

For emulsions, gels, and washes, this guide assigns glycerin a polyol-humectant role. Its level is not a batch assay.

3. Typical use levels (formulation guide)

• The stated reference for gels and serums is 3–8% as a formulation guide.
• Formulation guidance for creams: 2–5% for the formula.
• Formulation guidance for rinse-off: 2–4% in this reference.

Incorporate Glycerin in the water phase without a separate melt step.

4. Regulatory sources & global compliance

• A CosIng entry naming Glycerin does not by itself approve the purchased grade or complete cosmetic.
• EU cosmetics rules under Regulation (EC) No 1223/2009 require a safety assessment of the finished cosmetic containing Glycerin for the complete formula intended for sale.
• Check the supplier's technical information for the Glycerin grade and confirm the relevant market filing list.

5. Safety & risk assessment

The percentage is shown for cosmetic development; it makes no claim of drug or OTC authorization with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Keep the bulk container closed and shaded in a cool area; select packaging with the formula's oxidation sensitivity in mind; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Glycerin emphasizes humectant function.

• The listed information cannot verify drug claims, cure claims, or a certification that is absent from the product records.
• The ingredient record for Glycerin does not support whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• The level shown for gel-creams is 2–6% as a formulation guide.
• For dry oils, use 10–30% in this reference.
• The formulation record indicates 5–15% for balms.

Incorporate Squalane in the oil phase without a separate high-shear wax step.

4. Regulatory sources & global compliance

• If CosIng lists Squalane, that listing remains ingredient information; check rules for the intended market and use.
• The framework in Regulation (EC) No 1223/2009 requires a safety evaluation of the product containing Squalane as it will be marketed for the product in its final form.
• Confirm the received Squalane grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; it is not evidence of drug approval or OTC authorization and the completed formula still requires stability and patch testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; if the formula is oxidation-sensitive, an airless or pump format may be considered; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The cosmetic concept for Squalane in this entry centers on a light-emollient role.

• This ingredient reference does not substantiate a drug effect, a clinical cure, or certification status not established for the SKU.
• The information about Squalane is not evidence for a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

The butter role is assigned to shea in creams, balms, and hair creams. The reference makes no assumption about unrefined color or scent.

3. Typical use levels (formulation guide)

• The creams use-level reference is 2–8% as a formulation guide.
• For balms and butters, the reference gives 10–25% in this reference.

Melt Butyrospermum Parkii Butter into the oil phase, then cool under shear to help prevent graininess.

4. Regulatory sources & global compliance

• The CosIng record for Butyrospermum Parkii Butter, where listed, is informational rather than product-specific authorization.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Butyrospermum Parkii Butter is used for the completed formula, not simply for an ingredient in isolation.
• Compare the received Butyrospermum Parkii Butter material with its supplier specification and review destination-market filing needs.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; it should not be read as a drug authorization or OTC listing and the final formula should undergo patch and stability assessment.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; if oxidation risk calls for it, review a pump or airless format; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Butyrospermum Parkii Butter emphasizes shea cushion.

• The listed information does not support drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The ingredient record for Butyrospermum Parkii Butter does not confirm skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.